According to the Titanium Media App on July 20, some media reported that 141 drugs will be transferred out of Beijing Medical Insurance by the end of the year, including many commonly used drugs, such as ibuprofen, amlodipine and insulin, which has aroused public attention. On July 20, the Beijing Municipal Bureau of Medical Insurance responded to this, calling out amlodipine, clarithromycin, ibuprofen and other drugs in the non-national medical insurance drug catalog, but only deleted a certain dosage form of the related drugs, and the same kind of drugs were deleted. The drug is still in the medical insurance list. This adjustment provides a 6-month transition period for medical institutions to adjust their commonly used drug catalogues to ensure that clinical medication is not affected by the above adjustments. During the transition period, the medical insurance fund can continue to pay. The specific implementation time is December 31, 2022.
media coverage
Titanium Media 36Kr
Related events
- Beijing Medical Insurance Bureau responded to the call out of the supplementary list of drugs, and only deleted a certain dosage form in the related drugs2022-07-20
- 141 kinds of drugs will be transferred out of Beijing Medical Insurance by the end of the year2022-07-18
This article is reprinted from: https://readhub.cn/topic/8hNTGfiNt7E
This site is for inclusion only, and the copyright belongs to the original author.